Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures - 11/01/21
Abstract |
Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults.
Le texte complet de cet article est disponible en PDF.Key words : alternative medicine (AM), clinical guidelines for psoriasis, dermatology, guidelines, psoriasis, severity assessment, skin disease, topical agents
Abbreviations used : AAD, AM, AV, BSA, DLQI, FDA, HM, LCD, NB-UVB, NPF, PASI, PGA, PSI, RCT, UVA, UVB, US, WG
Plan
Funding sources: None. |
|
Conflicts of interest: Listed in text. |
|
IRB approval status: Not applicable. |
|
Reprints not available from the authors. |
Vol 84 - N° 2
P. 432-470 - février 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?